Evaluation of efficacy and safety of Unani Formulations in management Of Intithar al Shar (Chronic Telogen Effluvium) in healthy females.

Hair fall is a common cosmetic concern affecting about 1.7 percent of the global population often leading to psychological distress and reduced quality of life. The major types of hair loss include  telogen effluvium alopecia areata and androgenetic alopecia with varying prevalence worldwide and in India. Telogen effluvium one of the most frequent causes arises from a shortened anagen phase triggered by physiological or psychological stress. It occurs in acute and chronic forms and latter affecting mainly middle aged women without noticeable thinning but with decreased hair volume and length and often idiopathic in origin. The normal hair cycle consists of anagen 3 to 5 years catagen 2 to 3 weeks and telogen 3 to 4 months with daily shedding of up to 100 hairs considered normal but excessive shedding beyond this limit characterizes telogen effluvium. In Unani medicine hair loss Intithar al  shar is attributed to nutritional deficiencies impaired production of bukharat i dukhaniyya skin laxity morbid matter accumulation or fibrosis. Management includes drugs with properties such as Tadil e Mizaj (temperament correction) Taghziya (nutritional support) muqawwi e dimagh  (brain tonic) and Munbit e shar  (hair growth promotion). These formulations are considered safe with no adverse effects reported in classical literature .In contrast  modern medicine provides pharmacological and surgical options such as minoxidil  finasteride nutritional supplements  and low-level light therapy. However these require continuous use may have limited efficacy and are associated with adverse effects. Considering the safety and efficacy described in traditional texts the present study is designed to evaluate Unani polyherbal formulations in the management of chronic telogen effluvium in healthy females.